Vivian F. Martini
Introduction: Digestive disease conference covers subject relating and to reducing any health problem that occurs in the digestive tract. Conditions may range from mild to serious Intestinal problems, such as polyps and cancer, infections, celiac disease, Crohn disease, ulcerative colitis, diverticulitis, malabsorption, short bowel syndrome, and intestinal ischemia these are the some of the streams covered in the conference. Scope and importance: The main aim of this program will feature local and national speakers with expertise in endoscopy and gastroenterology topics will be covered to educate the broader gastroenterology community and referring physicians regarding management of inflammatory bowel disease in pregnancy, hepatitis B, microscopic colitis, dietary modifications in functional GI disorders, role of cholangioscopy in complex biliary disorders, patient selection for the LINX procedure for GERD, resection of colonic polyps and management of post polypectomy complications. Economic and Business: Digestive Diseases Market is expected to grow from USD 17.27 billion in 2016 and reach USD 19.79 billion in 2022, growing at a CAGR of 2.3% during the forecast period. Our industry experts anticipate that within the Digestive diseases market, the GIT Anti-inflammatory drug will grow at the fastest CAGR ranging from 1% to .5%, during the forecast period. Based on the geographic regions, our experts anticipate that Europe will be the fastest-growing segment during the forecast period. The Europe region will grow at a CAGR ranking from 1% to 0.3% by 2022
English 
Spanish 
Chinese 
Russian 
German 
Japanese 
Portuguese 
Hindi